Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

Two teams discover how small cell lung cancer hijacks neural pathways to proliferate faster, especially to the brain. Common ...

The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...

Doctors typically divide small cell lung cancer (SCLC) into limited or extensive stages, depending on whether the cancer is in one lung, both lungs, or has spread to distant areas. Staging for small ...

Most people with small cell lung cancer will have a recurrence. While several factors affect life expectancy, the outlook is typically less favorable. Treatment for recurrent small cell lung cancer is ...

The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

This partnership demonstrates the importance of multi-stakeholder engagement in addressing one of Canada's most urgent health challenges. By driving awareness and igniting innovation, Lung Cancer ...

Chemotherapy is a treatment that may be used for non-small cell lung cancer. It’s often used in combination with other treatment types. Chemotherapy is associated with a variety of risks and benefits.

A balloon-assisted endoscopy technique enables safe, direct access to peripheral lung fields for early lung cancer ...

Lung cancer stands as a formidable health challenge, claiming more lives globally than any other type of cancer. This ...